FDA Approved: FENOFIBRATE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application for fenofibrate submitted by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Hypertriglyceridemia
• Mixed Dyslipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)